(RTTNews) - Tuesday, Eli Lilly (LLY) said Zepbound 10 mg and 15 mg were associated with greater weight loss than Wegovy HD (semaglutide injection 7.2 mg) in a new indirect treatment comparison involving adults with obesity.
(RTTNews) - Mixed sentiment prevailed in Asian markets on Tuesday tracking the negative sentiment in Wall Street on Monday. Market mood was impacted by worries about a broad slowdown in AI development. Markets also digested the quarter percentage rate hike by Reserve Bank of Aust
(RTTNews) - Tuesday, BeyondSpring (BYSI) said the FDA granted Fast Track designation to Plinabulin plus docetaxel for advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) following progression on immune checkpoint inhibitor therapy and chemotherapy.
The S&P 500 Index ($SPX ) (SPY ) closed down by -0.77% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.08%. December E-mini S&P futures (ESZ26 ) fell -0.76%, and December E-mini...
(RTTNews) - 1-800-FLOWERS.COM Inc. (FLWS), a floral and gourmet foods gift retailer and distribution company, on Tuesday announced that it has agreed to sell PersonalizationMall.com and Things Remembered to PlanetArt LLC for approximately $45 million in cash.
Key PointsThe AI infrastructure build-out is the stock market’s hottest trend since the advent and proliferation of the internet in the mid-to-late 1990s.
Key PointsMeta Platforms has been investing heavily in artificial intelligence (AI) and recently launched many different subscription options related to AI.
(RTTNews) - Novo Nordisk A/S (NVO) reported that adults with type 2 diabetes who increased their dose of Ozempic (semaglutide) from 1 mg to 2 mg were associated with a statistically significant 6% lower risk of major adverse cardiovascular events (MACE) compared with patients who
(RTTNews) - Target Corp. (TGT), announced on Tuesday that it is lowering prices on nearly 2,000 home and apparel products as holiday shopping begins, adding to more than 10,000 reductions made over the past year.
In recent trading, shares of Rapid7 Inc (Symbol: RPD) have crossed above the average analyst 12-month target price of $11.73, changing hands for $11.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,